GIANNI', Luisa
 Distribuzione geografica
Continente #
NA - Nord America 365
AS - Asia 78
EU - Europa 71
SA - Sud America 14
Totale 528
Nazione #
US - Stati Uniti d'America 360
CN - Cina 34
IT - Italia 26
SG - Singapore 25
BR - Brasile 12
DE - Germania 10
RU - Federazione Russa 9
HK - Hong Kong 7
BE - Belgio 6
GB - Regno Unito 6
VN - Vietnam 6
CA - Canada 3
CH - Svizzera 3
PL - Polonia 3
FI - Finlandia 2
IN - India 2
MX - Messico 2
RO - Romania 2
SE - Svezia 2
VE - Venezuela 2
AT - Austria 1
BH - Bahrain 1
ES - Italia 1
IQ - Iraq 1
KR - Corea 1
TR - Turchia 1
Totale 528
Città #
Fairfield 68
Ashburn 45
Ann Arbor 39
Woodbridge 34
Houston 26
Seattle 25
Cambridge 21
Chandler 20
Wilmington 20
Singapore 12
Milan 8
Hong Kong 7
Brussels 6
Nanjing 6
Falls Church 5
Medford 5
Beijing 4
Dearborn 4
New York 4
Palermo 4
San Paolo di Civitate 4
Altamura 3
Boardman 3
Des Moines 3
Frankfurt am Main 3
Guangzhou 3
Lawrence 3
London 3
Ludwigshafen am Rhein 3
Princeton 3
Tianjin 3
Hanoi 2
Ho Chi Minh City 2
Los Angeles 2
Moscow 2
Shenyang 2
Taizhou 2
Zgierz 2
Zhengzhou 2
Zurich 2
Ankara 1
Berlin 1
Brasília 1
Brooklyn 1
Buffalo 1
Cabo Frio 1
Campo Grande 1
Canoas 1
Caracas 1
Carapicuíba 1
Charlotte 1
Chicago 1
Ciudad Juárez 1
Columbus 1
Düsseldorf 1
Engenheiro Paulo de Frontin 1
Gradisca D'isonzo 1
Hangzhou 1
Hartford 1
Hebei 1
Hefei 1
Helsinki 1
Kumar 1
Lanzhou 1
Lappeenranta 1
Makhachkala 1
Manama 1
Mexico City 1
Mirante da Serra 1
Montereale Valcellina 1
Montreal 1
Mumbai 1
Nanchang 1
Ningbo 1
Nova Russas 1
Nuremberg 1
Pamplona 1
Salto 1
San Diego 1
Santa Clara 1
Santiago 1
Seoul 1
São Paulo 1
Taiyuan 1
The Dalles 1
Toronto 1
Uberlândia 1
Valencia 1
Vancouver 1
Venice 1
Vienna 1
Warsaw 1
Washington 1
Zibo 1
Totale 469
Nome #
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success 245
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 178
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 116
Totale 539
Categoria #
all - tutte 2.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 1 7 2 28 15 2
2021/202252 2 11 1 5 3 4 2 2 9 2 5 6
2022/202361 7 15 2 4 10 8 2 2 9 0 1 1
2023/202424 0 4 2 5 2 4 4 0 0 1 0 2
2024/202559 1 2 10 6 2 4 2 3 3 10 5 11
2025/202678 16 10 9 23 12 8 0 0 0 0 0 0
Totale 539